Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q2 EPS by 55c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $71.86 --0%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of ($1.02), $0.55 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Surf Air Mobility names Palantir veteran as president of SurfOS
- CarMax (KMX) PT Raised to $47 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
